Aratana Theraptcs
(PETX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 41,431 | 66,868 | 87,307 | 26,755 | 9,823 |
| Marketable Securities | 1,240 | 747 | 996 | 59,447 | 88,249 |
| Receivables | 2,204 | 2,406 | 87 | 60 | 352 |
| Inventories | 11,425 | 13,576 | 11,130 | 1,306 | 427 |
| Income taxes - deferred | N/A | N/A | N/A | N/A | 158 |
| TOTAL | $58,127 | $85,239 | $101,542 | $89,019 | $99,909 |
| Non-Current Assets | |||||
| PPE Net | 693 | 1,166 | 1,948 | 2,555 | 620 |
| Investments And Advances | 0 | 0 | 0 | 0 | 2,452 |
| Intangibles | 46,945 | 47,911 | 47,021 | 54,848 | 103,721 |
| Other Non-Current Assets | 671 | 876 | 895 | 644 | 1,201 |
| TOTAL | $48,309 | $49,953 | $49,864 | $58,047 | $107,994 |
| Total Assets | $106,436 | $135,192 | $151,406 | $147,066 | $207,903 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 17,333 | 14,413 | N/A | N/A |
| Accounts payable and accrued liabilities | 911 | 7,451 | 7,436 | 1,400 | 1,532 |
| Accrued Expenses | 4,646 | 3,712 | 5,827 | 4,247 | 3,229 |
| Other current liabilities | N/A | 7,000 | 7,012 | 37 | 4,294 |
| TOTAL | $5,557 | $35,496 | $34,688 | $5,684 | $9,468 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 19,492 | 25,775 | 39,710 | 14,963 |
| Other Non-Current Liabilities | 57 | 70 | 540 | 122 | 30 |
| TOTAL | $57 | $19,562 | $26,315 | $39,832 | $16,603 |
| Total Liabilities | $5,614 | $55,058 | $61,003 | $45,516 | $26,071 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 48,974 | 45,854 | 37,363 | 35,355 | 34,910 |
| Common Shares | 48 | 43 | 37 | 35 | 34 |
| Retained earnings | -241,238 | -233,316 | -185,593 | -152,018 | -67,964 |
| Other shareholders' equity | -7,733 | -7,192 | -9,950 | -9,408 | -4,231 |
| TOTAL | $100,822 | $80,134 | $90,403 | $101,550 | $181,832 |
| Total Liabilities And Equity | $106,436 | $135,192 | $151,406 | $147,066 | $207,903 |